Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.

Li X, Jabbarzadeh Kaboli P, Roozitalab G, Salahi S, Qian H, Zhang X, Chen K, Imani S

DOI: 10.1007/s13402-026-01199-1
Published: 2026 Apr 15
Container: Cellular oncology (Dordrecht, Netherlands)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13402-026-01199-1,
  title = {Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.},
  author = {Li X and Jabbarzadeh Kaboli P and Roozitalab G and Salahi S and Qian H and Zhang X and Chen K and Imani S},
  year = {2026},
  journal = {Cellular oncology (Dordrecht, Netherlands)},
  doi = {10.1007/s13402-026-01199-1},
  url = {https://doi.org/10.1007/s13402-026-01199-1}
}

RIS

TY  - JOUR
TI  - Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.
AU  - Li X
AU  - Jabbarzadeh Kaboli P
AU  - Roozitalab G
AU  - Salahi S
AU  - Qian H
AU  - Zhang X
AU  - Chen K
AU  - Imani S
PY  - 2026
JO  - Cellular oncology (Dordrecht, Netherlands)
DO  - 10.1007/s13402-026-01199-1
UR  - https://doi.org/10.1007/s13402-026-01199-1
ER  -

APA

X, L., P, J. K., G, R., S, S., H, Q., X, Z., K, C., & S, I. (2026). Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.. Cellular oncology (Dordrecht, Netherlands). https://doi.org/10.1007/s13402-026-01199-1

Source records

pubmed · retrieved 2026-09-26T09:59:13.279Z